ACCURAY INCORPORATED (NASDAQ:ARAY) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Conditions.
On January 22, 2019, Accuray Incorporated (the “Company”) issued a press release announcing its financial results for the second quarter ended December 31, 2018. A copy of the Company’s press release dated January 22, 2019, titled “Accuray Reports Fiscal 2019 Second Quarter Results” is attached hereto as Exhibit99.1 and is incorporated herein by reference.
The foregoing information (including the exhibit hereto) is being furnished under “Item 2.02 Results of Operations and Financial Condition” and shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
ACCURAY INC Exhibit
EX-99.1 2 aray-ex991_8.htm EX-99.1 aray-ex991_8.htm Exhibit 99.1 Doug Sherk Beth Kaplan Investor Relations,…
To view the full exhibit click
About ACCURAY INCORPORATED (NASDAQ:ARAY)
Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.